Eye Smart—American Ophthalmology http://www.geteyesmart.org
National Eye Institute (NEI) http://www.nei.nih.gov
Canadian Ophthalmological Society http://www.cos-sco.ca
The Canadian National Institute for the Blind http://www.cnib.ca
Amblyopia. EBSCO DynaMed Plus website. Available at: http://www.dynamed.com/topics/dmp~AN~T114848/Amblyopia. Updated January 8, 2016. Accessed September 26, 2016.
Bhola R, Keech RV, et al. Recurrence of amblyopia after occlusion therapy.
Campos, EC, Schiavi, et al. Effect of citicoline on visual acuity in amblyopia: preliminary results.
Graefes Arch Clin Exp Ophthalmol.1995;233(5):307-312.
Fleck BW. Amblyopia therapy.
Br J Ophthalmol. 2003;87(3):255-266.
Flynn JT, Schiffman J, et al. The therapy of amblyopia: An analysis of the results of amblyopia therapy utilizing the pooled data of published studies.
Trans Am Ophthalmol Soc. 1998;96: 431-450; discussion 450-453.
Holmes JM, Beck RW, et al. Pediatric Eye Disease Investigator Group. Impact of patching and atropine treatment on the child and family in the amblyopia treatment study.
Arch Ophthalmol. 2003;121(11):1625-1632.
Kushner BJ. Atropine vs. patching for the treatment of moderate amblyopia in children.
LaRoche GR. Amblyopia: Detection, prevention, and rehabilitation.
Curr Opin Ophthalmol. 2001;12(5):363-367.
Leguire LE, Rogers GL, et al. Occlusion and levodopa-carbidopa treatment for childhood amblyopia.
Loudon SE, Simonsz HJ. The history of the treatment of amblyopia.
Ohlsson J, Baumann M, et al. Long term visual outcome in amblyopia treatment.
Br J Ophthalmol. 2002; 86(10):1148-51.
Pediatric Eye Disease Investigator Group. A comparison of atropine and patching treatments for moderate amblyopia by patient age, cause of amblyopia, depth of amblyopia, and other factors.
Ophthalmology. 2003;110(8):1632-7; discussion 1637-8.
Powell C, Porooshani H, et al. Screening for amblyopia in childhood.
Cochrane Database Syst Rev. 2005;(3):CD005020.
Quinn GE, Beck RW, et al. Pediatric Eye Disease Investigator Group. Recent advances in the treatment of amblyopia.
Pediatrics. 2004;113 (6):1800-1802.
Sakatani K, Jabbur NS, et al. Improvement in best corrected visual acuity in amblyopic adult eyes after laser in situ keratomileusis.
J Cataract Refract Surg. 2004;30(12):2517-2521.
Simons K. Amblyopia characterization, treatment, and prophylaxis.
Surv Ophthalmol. 2005;50(2):123-166.
5/28/2010 DynaMed Plus Systematic Literature Surveillance
http://www.dynamed.com/topics/dmp~AN~T114848/Amblyopia: Pediatric Eye Disease Investigator Group Writing Committee, Rutstein RP, Quinn GE, et al. A randomized trial comparing Bangerter filters and patching for the treatment of moderate amblyopia in children.
2/4/2011 DynaMed Plus Systematic Literature Surveillance
http://www.dynamed.com/topics/dmp~AN~T114848/Amblyopia: US Preventive Services Task Force.
Vision screening for children 1 to 5 years of age: US Preventive Services Task Force recommendation statement.
This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.
Copyright © 2012 EBSCO Publishing
All rights reserved.
It's time to stop guessing. If you want to make some changes but just aren't sure how, the free personal health survey from LiveWell is a great place to start.
Fight heart disease and prevent heart attacks. HeartSHAPE® is a painless, non-invasive test that checks pictures of your heart for early-stage coronary disease.
How many calories do you need to eat each day to maintain your weight and fuel your physical activity? Enter a few of your stats into this calculator to find out.
Using body mass index as a reference, this calculator determines your ideal body weight range. All you need to do is enter your height.
This tool considers your height and weight to assess your weight status.
Wellmont Nurse Connection is your resource for valuable health information any time, 24 hours a day, seven days a week. Speak to a Nurse any time, day or night, at (423) 723-6877 or toll-free at 1-877-230-NURSE.
You clicked on a link that will cause you to leave myWellmont.
For security purposes you will be signed out.